These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4546859)

  • 41. The effect of splenectomy on tumor immunity and the metastatic spread of a murine reticulum cell sarcoma.
    Faraci RP; Marrone JC; Lesser GR; Ketcham AS
    Panminerva Med; 1975 Mar; 17(3):59-64. PubMed ID: 1096028
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells.
    Law LW; Ting RC; Leckband E
    Proc Natl Acad Sci U S A; 1967 Apr; 57(4):1068-75. PubMed ID: 4291920
    [No Abstract]   [Full Text] [Related]  

  • 43. Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity.
    Evans R; Booth CG; Spencer F
    Br J Cancer; 1978 Nov; 38(5):583-90. PubMed ID: 310310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Normal tissue antigens of tumor cells.
    Milas L; Suit HD
    Tex Rep Biol Med; 1969; 27(2):467-9. PubMed ID: 4900374
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of regional lymphadenectomy on development of concomitant immunity.
    Soloway MS; Pendergrast WJ; Myers GH
    Surg Forum; 1972; 23(0):101-2. PubMed ID: 4671039
    [No Abstract]   [Full Text] [Related]  

  • 46. Specificity of T cell responses to murine chemically-induced tumor antigens.
    Perry LL; Ziegler HK; Brunner B
    Prog Clin Biol Res; 1987; 244():147-57. PubMed ID: 3309997
    [No Abstract]   [Full Text] [Related]  

  • 47. Modulation of growth of malignant cells by anti-idiotypic immunity.
    Schreiber H; Flood PM; Kripke ML; Urban JL
    Haematol Blood Transfus; 1981; 26():368-71. PubMed ID: 6976294
    [No Abstract]   [Full Text] [Related]  

  • 48. Metastatic spread of human tumour implanted into thymectomized, antithymocyte serum treated hamsters.
    Cobb LM
    Br J Cancer; 1972 Jun; 26(3):183-9. PubMed ID: 5047142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
    Vaage J; Jones RD; Brown BW
    Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of select T cell depletion in modulating the behavior of fibrosarcomas in mice.
    Gupta S; Sehgal S; Aikat BK
    Indian J Med Res; 1978 Aug; 68():300-5. PubMed ID: 309864
    [No Abstract]   [Full Text] [Related]  

  • 51. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 52. Macrophages and cancer metastasis.
    Fidler IJ; Poste G
    Adv Exp Med Biol; 1982; 155():65-75. PubMed ID: 6984285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities.
    Fidler IJ; Gersten DM; Kripke ML
    Cancer Res; 1979 Oct; 39(10):3816-21. PubMed ID: 476618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homing of macrophages in tumor immunity.
    Gupta N; Aikat BK; Sehgal S
    Indian J Med Res; 1982 Sep; 76():424-9. PubMed ID: 7174033
    [No Abstract]   [Full Text] [Related]  

  • 55. Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice.
    Elgert KD; Connolly KM
    Oncology; 1980; 37(2):101-6. PubMed ID: 6444706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 57. Tumor growth in the guinea pig: alpha globulin changes associated with lymphocyte suppression.
    Lilley DP; Burger DR; Vetto RM
    J Natl Cancer Inst; 1974 Sep; 53(3):701-9. PubMed ID: 4138027
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of azathioprine on host cell infiltration and growth of a murine fibrosarcoma.
    Evans R
    Int J Cancer; 1977 Jul; 20(1):120-8. PubMed ID: 903180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequestration of macrophages in growing tumours and its effect on the immunological capacity of the host.
    Eccles SA; Alexander P
    Br J Cancer; 1974 Jul; 30(1):42-9. PubMed ID: 4415734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.